[Japon] Japan to shoulder COVID vaccine liability risks
Auteur : Kosuke Takeuchi, Nikkei staff writer
Production : Nikkei
Diffusion : site de Nikkei Asian Review
Date : 20 août 2020
Government to compensate for side effects, in bid to secure stable supply
TOKYO — Japan’s government plans to cover compensation for any health problems that may arise here from coronavirus vaccines, seeking to ensure a stable supply from foreign manufacturers as global competition intensifies, Nikkei has learned.
Source : Kosuke Takeuchi, « Japan to shoulder COVID vaccine liability risks », Nikkei Asian Review, 20/08/2020. URL : https://asia.nikkei.com/Business/Pharmaceuticals/Japan-to-shoulder-COVID-vaccine-liability-risks (consulté le 20/08/2020)
Photo « à la une » : Nearly 30 coronavirus vaccine candidates have entered clinical trials, according to the World Health Organization, as drugmakers compress their development timelines. (Photo by Tomoki Mera)
OpenEdition vous propose de citer ce billet de la manière suivante :
IAOdocJ (20 août 2020). [Japon] Japan to shoulder COVID vaccine liability risks. Asie Orientale et Coronavirus. Consulté le 16 février 2025 à l’adresse https://doi.org/10.58079/n7lv